Distinguished in Age-Related Macular Degeneration (ARMD)

Dr. Hugo Quiroz-Mercado

Ophthalmology
777 Bannock St, Mc 7782, 
Denver, CO 

Distinguished in Age-Related Macular Degeneration (ARMD)
777 Bannock St, Mc 7782, 
Denver, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hugo Quiroz-Mercado is an Ophthalmologist in Denver, Colorado. Dr. Quiroz-Mercado is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Blepharitis, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles and participated in 2 clinical trials in the study of Age-Related Macular Degeneration (ARMD).

Specialties
Ophthalmology
Licenses
Ophthalmology in CO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

777 Bannock St, Mc 7782, Denver, CO 80204
Call: 303-436-6000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Enrollment Status: Withdrawn
Publish Date: June 05, 2024
Intervention Type: Drug
Study Drug: Bevacizumab
Study Phase: Phase 2/Phase 3
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Enrollment Status: Terminated
Publish Date: June 03, 2024
Intervention Type: Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 3
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Enrollment Status: Terminated
Publish Date: May 31, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Drug: Bevacizumab
Study Phase: Phase 3
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure, Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 2/Phase 3
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

97 Total Publications

Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Journal: Current therapeutic research, clinical and experimental
Published: December 13, 2024
View All 97 Publications
Similar Doctors
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Naresh Mandava
Ophthalmology
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Naresh Mandava
Ophthalmology

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (8.0 miles away)
720-848-0000
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Naresh Mandava is an Ophthalmologist in Aurora, Colorado. Dr. Mandava is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Vitrectomy, and Cataract Removal. Dr. Mandava is currently accepting new patients.

Elite in Age-Related Macular Degeneration (ARMD)
Dr. Marc T. Mathias
Ophthalmology
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Marc T. Mathias
Ophthalmology

University Physicians Incorporated

1675 Aurora Ct, 
Aurora, CO 
 (8.1 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marc Mathias is an Ophthalmologist in Aurora, Colorado. Dr. Mathias is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Hormone Replacement Therapy (HRT). Dr. Mathias is currently accepting new patients.

Elite in Age-Related Macular Degeneration (ARMD)
Dr. Niranjan Manoharan
Ophthalmology
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Niranjan Manoharan
Ophthalmology

Denver Health And Hospital Authority

777 Bannock St, 
Denver, CO 
 (0.1 miles away)
303-436-6000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Niranjan Manoharan is an Ophthalmologist in Denver, Colorado. Dr. Manoharan is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Manoharan is currently accepting new patients.

VIEW MORE AGE-RELATED MACULAR DEGENERATION (ARMD) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Quiroz-Mercado's expertise for a condition
ConditionClose
  • Elite
  • Vitrectomy
    Dr. Quiroz-Mercado is
    Elite
    . Learn about Vitrectomy.
    See more Vitrectomy experts
  • Distinguished
  • Age-Related Macular Degeneration (ARMD)
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Age-Related Macular Degeneration (ARMD).
    See more Age-Related Macular Degeneration (ARMD) experts
  • Blepharitis
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Blepharitis.
    See more Blepharitis experts
  • Diabetic Macular Edema (DME)
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Diabetic Macular Edema (DME).
    See more Diabetic Macular Edema (DME) experts
  • Diabetic Retinopathy
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Diabetic Retinopathy.
    See more Diabetic Retinopathy experts
  • Late-Onset Retinal Degeneration
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Late-Onset Retinal Degeneration.
    See more Late-Onset Retinal Degeneration experts
  • Retinal Detachment
    Dr. Quiroz-Mercado is
    Distinguished
    . Learn about Retinal Detachment.
    See more Retinal Detachment experts
View All 7 Distinguished Conditions
  • Advanced
  • Color Blindness
    Dr. Quiroz-Mercado is
    Advanced
    . Learn about Color Blindness.
    See more Color Blindness experts
  • Experienced
  • Brown Syndrome
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Brown Syndrome.
    See more Brown Syndrome experts
  • Cataract
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Cataract.
    See more Cataract experts
  • Cataract Removal
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Cataract Removal.
    See more Cataract Removal experts
  • Dry Eye Syndrome
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Dry Eye Syndrome.
    See more Dry Eye Syndrome experts
  • Endophthalmitis
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Endophthalmitis.
    See more Endophthalmitis experts
  • Geographic Atrophy
    Dr. Quiroz-Mercado is
    Experienced
    . Learn about Geographic Atrophy.
    See more Geographic Atrophy experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved